KRAS and colorectal carcinoma: Moreover, according to one study, the activation of the KRAS/BRAF/phosphoinositide 3-kinase (PI3K) oncogenic pathway by KRAS and BRAFV600E mutations induces the expression of the key autophagic markers lLC3 and Beclin-1 in CRC cells, thus promoting autophagy [85].